Welcome to our dedicated page for DLH Holdings news (Ticker: DLHC), a resource for investors and traders seeking the latest updates and insights on DLH Holdings stock.
DLH Holdings Corp. provides science research and development, systems engineering and integration, digital transformation, and cybersecurity solutions for federal government customers. Its news commonly covers financial results, operating trends, cash flow, debt reduction, backlog, and the impact of federal contracting conditions on revenue.
Company updates also focus on health and national security missions, including work for agencies such as NIH, HHS, VA, DoD, and related sub-agencies. Recurring themes include information technology task orders, enterprise systems management, cloud computing, software development, telehealth systems, artificial intelligence, advanced analytics, and cybersecurity certifications such as CMMC Level 2.
DLH Holdings (NASDAQ: DLHC) reported fiscal Q1 ended Dec 31, 2025 results with revenue of $68.9M (down 24.1% YoY) and Adjusted EBITDA of $6.5M (9.5% of revenue). The revenue decline reflects transition of legacy programs to small-business set-aside contractors.
Operating cash usage improved to $4.8M (vs. $11.5M prior year), debt modestly rose to $136.6M, and backlog remained largely stable at $517.4M. Management said cost rightsizing supported margins and that it intends to deploy future operating cash flow toward delevering.
DLH Holdings (NASDAQ: DLHC) will release fiscal 2026 first quarter results for the period ended December 31, 2025 on February 9, 2026 after market close.
A conference call with senior management will be held on February 10, 2026 at 10:00 a.m. ET to present results and discuss operating trends; presentation materials and a replay will be posted on the company's Investor Relations website.
DLH Holdings (NASDAQ: DLHC) reported fiscal Q4 results for the period ended September 30, 2025, showing mixed performance as budgetary priorities affected revenue. Revenue was $81.2M, down (15.8)% year-over-year. The company delivered EBITDA $6.6M and free cash flow $10.7M. DLH reduced debt to $131.6M (down 14.9% year-over-year) and reported backlog of $514.3M (down 25.5%). Net loss was $(0.9)M and diluted EPS was $(0.06). Management cited continued investments in new business and scaling initiatives and scheduled an earnings webcast for December 11, 2025 at 10:00 AM ET.
DLH Holdings (NASDAQ: DLHC) will release fiscal 2025 fourth quarter results for the period ended September 30, 2025 on December 10, 2025 after market close.
The company will host a conference call for investors on December 11, 2025 at 10:00 a.m. ET featuring a brief management presentation on financial results and operating trends, followed by Q&A. Dial-in numbers: 888-347-5290 or 412-317-5256. Presentation materials will be posted on DLH Investor Relations prior to the call.
A digital replay will be available about two hours after the call via the DLH Investor Relations site or by dialing 1-855-669-9658 and entering conference ID 7526746. For investor inquiries contact Chris Witty at cwitty@darrowir.com or 646-438-9385.
DLH (NASDAQ: DLHC) announced on October 22, 2025 that it achieved CMMC Level 2 certification. The certification required a rigorous audit verifying compliance with over 100 security requirements based on NIST standards to protect sensitive unclassified Department of Defense data.
The company said the certification validates its ability to support national security missions and positions DLH to compete for new DoD solicitations as CMMC 2.0 requirements begin appearing in bids as early as November 2025.
DLH Holdings (NASDAQ: DLHC) has secured a task order worth up to $46.9 million to continue providing IT services to the National Institutes of Health's Office of Information Technology. The contract includes a base period plus options totaling a three-year performance period.
The company will deliver enterprise IT systems management, cybersecurity, software development, and cloud computing services, supporting approximately 7,000 end-customers. DLH will implement a cloud migration strategy leveraging partnerships with Azure, AWS, and Google, while focusing on digital transformation and system modernization initiatives.
DLH Holdings (NASDAQ:DLHC) reported its fiscal Q3 2025 results, with revenue declining to $83.3 million from $100.7 million in Q3 2024, primarily due to small business conversions and program timing. Net income decreased to $0.3 million ($0.02 per diluted share) from $1.1 million ($0.08 per diluted share) year-over-year.
The company demonstrated strong cash flow management, reducing total debt to $142.3 million from $154.6 million at fiscal year start, including a $9.4 million reduction during Q3. EBITDA was $8.1 million (9.7% of revenue) compared to $10.0 million (10.0% of revenue) in the prior year. Contract backlog stood at $555.3 million, with $92.3 million funded.
The company remains focused on cybersecurity, digital transformation, and public health initiatives, positioning itself for growth in fiscal 2026 amid increased defense spending and technology integration priorities.DLH Holdings (NASDAQ: DLHC), a provider of science research, systems engineering, and digital transformation solutions to federal agencies, has scheduled its fiscal 2025 third quarter financial results announcement for August 6, 2025 after market close.
The company will host a conference call on August 7, 2025, at 10:00 a.m. Eastern Time, featuring management presentations and a Q&A session. Investors can access the call via dial-in numbers 888-347-5290 or 412-317-5256. A digital recording will be available through the DLH Investor Relations website or by dialing 877-344-7529 (conference ID: 1191990).
DLH Holdings Corp. (NASDAQ: DLHC) has secured a five-year task order worth up to $37.7 million to continue providing advanced technology services to the Telemedicine and Advanced Technology Research Center (TATRC). The contract, awarded under the OMNIBUS IV procurement vehicle, involves delivering scientific R&D, modeling & simulation, AI, machine learning, robotic process automation, biomedical engineering, and cloud-enabled big data analytics.
The company will support TATRC and the US Army Medical Research & Development Command (MRDC) in their mission to improve medical outcomes for military service members through the fusion of data, humans, and machines. This continuation builds on DLH's 20-year partnership with the medical research & development community, leveraging their comprehensive suite of technology-enabled research and advanced engineering solutions.
[ "Secured a significant $37.7 million task order for a five-year period", "Continuation of a 20-year partnership, demonstrating strong client relationships", "Contract strengthens position in military health and adjacent markets", "Leverages advanced technologies including AI, ML, and cloud computing" ]